Altrazeal Life Sciences
Developer and distributor of a sterile powder-to-matrix wound dressing technology for extended-wear wound management and a water-erodible transmucosal drug-delivery device. The company supports clinical research (randomized trials, prospective and retrospective studies, conference posters) and provides ordering, distribution, and customer support for use across surgical, traumatic, chronic and pediatric wounds, including diabetic foot ulcers, venous/vascular ulcers, pressure injuries, burns and skin-graft sites. The dressing is marketed for application to moist wounds where granules hydrate and form a flexible, wound-conforming polymer matrix.
Industries
N/A
Nr. of Employees
small (1-50)
Altrazeal Life Sciences
4410 Beltway Drive, Addison, TX 75001, United States
Patents
Method of formation of shape-retentive aggregates of gel particles and their uses
US-7811605-B2
View Details
Method of formation of shape-retentive aggregates of gel particles and their uses
US-7811605-B2
View DetailsProducts
Powder-to-matrix wound dressing (sterile granule dressing)
Sterile granule dressing that hydrates with wound exudate to form a moist, flexible, oxygen-permeable film which seals and contours to the wound bed; intended as a primary extended-wear dressing across surgical, traumatic and chronic wounds and graft sites.
Water-erodible transmucosal drug-delivery device
Multi-layered, water-erodible carrier designed for application to mucosal surfaces to deliver actives locally or systemically with controlled erosion and release rates.
Powder-to-matrix wound dressing (sterile granule dressing)
Sterile granule dressing that hydrates with wound exudate to form a moist, flexible, oxygen-permeable film which seals and contours to the wound bed; intended as a primary extended-wear dressing across surgical, traumatic and chronic wounds and graft sites.
Water-erodible transmucosal drug-delivery device
Multi-layered, water-erodible carrier designed for application to mucosal surfaces to deliver actives locally or systemically with controlled erosion and release rates.
Services
Partnerships with clinical sites and investigators to support study design, participation in prospective randomized and observational studies, and dissemination of results via posters and abstracts.
Provider and patient ordering channels for sterile powder dressings plus documented returns and complaint processes and adverse event reporting guidance.
Partnerships with clinical sites and investigators to support study design, participation in prospective randomized and observational studies, and dissemination of results via posters and abstracts.
Provider and patient ordering channels for sterile powder dressings plus documented returns and complaint processes and adverse event reporting guidance.
Expertise Areas
- Powder-to-matrix wound dressing development
- Chronic and acute wound management
- Clinical trial design and execution (including randomized trials and Phase IV studies)
- Clinical evidence generation and conference dissemination
Key Technologies
- Powder-to-matrix wound dressing
- Methacrylate-based polymer matrices
- Oxygen-permeable dressing materials
- Moisture vapor transmission control
News & Updates
Repository of randomized controlled trials, prospective and retrospective studies, case series and over 85 conference abstracts and posters reporting use across multiple wound types (surgical, vascular/venous, trauma, burns, pressure injuries).
Repository of randomized controlled trials, prospective and retrospective studies, case series and over 85 conference abstracts and posters reporting use across multiple wound types (surgical, vascular/venous, trauma, burns, pressure injuries).